| Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor AM Kalle, A Rizvi Antimicrobial agents and chemotherapy 55 (1), 439-442, 2011 | 93 | 2011 |
| Rewiring of Metabolic Network in Mycobacterium tuberculosis During Adaptation to Different Stresses A Rizvi, A Shankar, A Chatterjee, TH More, T Bose, A Dutta, ... Frontiers in Microbiology 10, 2417, 2019 | 41 | 2019 |
| Genetic mechanisms governing sporulation initiation in Clostridioides difficile CD Lee, A Rizvi, AN Edwards, MA DiCandia, GGV Cuebas, MP Monteiro, ... Current opinion in microbiology 66, 32-38, 2022 | 28 | 2022 |
| Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers A Albors-Vaquer, A Rizvi, M Matzapetakis, P Lamosa, AV Coelho, ... Emerging microbes & infections 9 (1), 1131-1139, 2020 | 24 | 2020 |
| Understanding HIV-Mycobacteria synergism through comparative proteomics of intra-phagosomal mycobacteria during mono-and HIV co-infection R Ganji, S Dhali, A Rizvi, S Rapole, S Banerjee Scientific reports 6 (1), 1-14, 2016 | 24 | 2016 |
| Metabolomics studies to decipher stress responses in Mycobacterium smegmatis point to a putative pathway of methylated amine biosynthesis A Rizvi, S Yousf, K Balakrishnan, HK Dubey, SC Mande, J Chugh, ... Journal of bacteriology 201 (15), 10.1128/jb. 00707-18, 2019 | 18 | 2019 |
| Proteomics approach to understand reduced clearance of mycobacteria and high viral titers during HIV–mycobacteria co‐infection R Ganji, S Dhali, A Rizvi, S Sankati, MH Vemula, G Mahajan, S Rapole, ... Cellular Microbiology 18 (3), 355-368, 2016 | 18 | 2016 |
| Phenolic-glycolipid-1 and lipoarabinomannan preferentially modulate TCR-and CD28-triggered proximal biochemical events, leading to T-cell unresponsiveness in mycobacterial diseases PK Dagur, B Sharma, R Upadhyay, B Dua, A Rizvi, NA Khan, VM Katoch, ... Lipids in health and disease 11, 1-10, 2012 | 18 | 2012 |
| Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort R Conde, R Laires, LG Gonçalves, A Rizvi, C Barroso, M Villar, R Macedo, ... biomedical journal 45 (4), 654-664, 2022 | 17 | 2022 |
| Host manipulation by bacterial type III and type IV secretion system effector proteases F Viana, SS Peringathara, A Rizvi, GN Schroeder Cellular Microbiology 23 (11), e13384, 2021 | 13 | 2021 |
| An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors P Khadkikar, NS Goud, A Mohammed, G Ramamoorthy, ... Chemical Biology & Drug Design 92 (6), 1933-1939, 2018 | 13 | 2018 |
| Structural basis of hypoxic gene regulation by the Rv0081 transcription factor of Mycobacterium tuberculosis A Kumar, S Phulera, A Rizvi, PJ Sonawane, HS Panwar, S Banerjee, ... FEBS letters 593 (9), 982-995, 2019 | 8 | 2019 |
| Mycobacterium oryzae sp. nov., a scotochromogenic, rapidly growing species is able to infect human macrophage cell line EVV Ramaprasad, A Rizvi, S Banerjee, C Sasikala, CV Ramana International Journal of Systematic and Evolutionary Microbiology 66 (11 …, 2016 | 7 | 2016 |
| Glycine fermentation by C. difficile promotes virulence and spore formation, and is induced by host cathelicidin A Rizvi, G Vargas-Cuebas, AN Edwards, MA DiCandia, ZA Carter, ... Infection and Immunity 91 (10), e00319-23, 2023 | 2 | 2023 |
| Antibacterial Nanoparticles Based on Fluorescent 3‐Substituted Uridine Analogue ER Reddy, AM Yaseen, A Rizvi, GS Deora, S Banerjee, A Sevilimedu, ... ChemistrySelect 2 (1), 557-561, 2017 | 1 | 2017 |
| Confronting Tuberculosis: A Synthetic Quinoline-Isonicotinic Acid Hydrazide Hybrid Compound as a Potent Lead Molecule Against Mycobacterium tuberculosis GR Vadankula, VV Nilkanth, A Rizvi, S Yandrapally, A Agarwal, H Chirra, ... ACS Infectious Diseases, 2024 | | 2024 |
| The predicted acetoin dehydrogenase pathway represses sporulation of Clostridioides difficile D Wetzel, A Rizvi, AN Edwards, SM McBride bioRxiv, 2023.07. 28.551048, 2023 | | 2023 |
| Metabolomics approach to understand mycobacterial adaptation to stree and identify disease markers A Rizvi University of Hyderabad, 2018 | | 2018 |
